Capillary whole-blood IgG-IgM COVID-19 self-test as a serological screening tool for SARS-CoV-2 infection adapted to the general public
Table 2
Analytical results of the evaluation questionnaire concerning the ability of the 167 study participants to understand the instruction for use of the Exacto® COVID-19 self-test (Biosynex Swiss SA) (substudy 1).
The questions raising specific issues concerning the manipulation of the kit, the interpretation of test results, and the consequence of test results, were asked by the observer and the answers were closed.